Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients
Aim: Lung cancer is considered to be the most common cancer in the world. In humans, about 50% or more cancers have a mutated tumor suppressor p53 gene thereby resulting in accumulation of p53 protein and losing its function to activate the target genes that regulate the cell cycle and apoptosis. Ex...
Main Authors: | Rashid Mir, Mirza Masroor, Jamsheed Javid, Imtiyaz Ahamad, Shazia Farooq, Prasant Yadav, Mariyam Zuberi, Maqbool Lone, P C Ray, Alpana Saxena |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2016-01-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2016;volume=5;issue=1;spage=33;epage=36;aulast=Mir |
Similar Items
-
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?
by: Amit Joshi, et al.
Published: (2018-01-01) -
Identifying Prognostic Groups Using Machine Learning Tools in Patients Undergoing Chemoradiation for Inoperable Locally Advanced Nonsmall Cell Lung Carcinoma
by: Anjali K. Pahuja, et al.
Published: (2019-07-01) -
Investigation of p53 codon72 polymorphism in oral squamous cell carcinoma (SCC) specimens and normal population by PCR
by: Deyhimi P., et al.
Published: (2008-10-01) -
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
by: Gee-Chen Chang, et al.
Published: (2013-09-01) -
Surgical Resection for Patients With Mucinous Bronchioloalveolar Carcinoma
by: Souichi Oka, et al.
Published: (2010-04-01)